Overexpression of Tumor Vascular Endothelial Growth Factor A May Portend an Increased Likelihood of Progression in a Phase II Trial of Bevacizumab and Erlotinib in Resistant Ovarian CancerSetsuko K. Chambers, David S. Alberts, Mary C. Clouser et al.|Clinical Cancer Research|2010Cited by 55
Phase I Trial of Intraperitoneal Pemetrexed, Cisplatin, and Paclitaxel in Optimally Debulked Ovarian CancerSetsuko K. Chambers, David S. Alberts, Nisreen Abu Shahin et al.|Clinical Cancer Research|2012Cited by 32
4‐HPR modulates gene expression in ovarian cellsMolly Brewer, Changping Zou, Urs Utzinger et al.|International Journal of Cancer|2006Cited by 9